Produktname:N-[2-(2,6-dioxo-3-piperidyl)-1-oxo-isoindolin-4-yl]-2-methoxy-acetamide
IUPAC Name:N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-4-yl]-2-methoxyacetamide
- CAS:2321264-58-6
- Molekulare Formel:C16H17N3O5
- Reinheit:95%
- Katalognummer:CM1077027
- Molekulargewicht:331.33
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2321264-58-6
- Molekulare Formel:C16H17N3O5
- Schmelzpunkt:-
- SMILES-Code:COCC(=O)NC1=C2CN(C3CCC(=O)NC3=O)C(=O)C2=CC=C1
- Dichte:
- Katalognummer:CM1077027
- Molekulargewicht:331.33
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- PROTAC-E3 Ligase Ligands
- Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
- PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.